1-(carboxymethylthio)tetradecane has been researched along with phosphorus in 1 studies
| Studies (1-(carboxymethylthio)tetradecane) | Trials (1-(carboxymethylthio)tetradecane) | Recent Studies (post-2010) (1-(carboxymethylthio)tetradecane) | Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) |
|---|---|---|---|---|---|
| 143 | 5 | 32 | 48,074 | 1,126 | 17,139 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berge, RK; Eiane, SA; Helleland, C; Holmsen, H; Lillehaug, JR | 1 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and phosphorus
| Article | Year |
|---|---|
1-(Carboxymethylthio)tetradecane attenuates PDGF- and TPA-induced c-fos mRNA expression and increases the formation of phosphatidylethanolamine with a shift from less to more polar molecular species in C3H/10T1/2 cells.
Topics: Animals; Anticoagulants; Becaplermin; Blotting, Western; Carcinogens; Cell Line; Dose-Response Relationship, Drug; Gene Expression; Mice; Mice, Inbred C3H; Phosphatidic Acids; Phosphatidylethanolamines; Phosphorus; Phosphorus Radioisotopes; Platelet-Derived Growth Factor; Precipitin Tests; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-sis; RNA, Messenger; Sulfides; Tetradecanoylphorbol Acetate; Time Factors | 1997 |